What is Touch Bionics?
Touch Bionics, operating under Össur Touch Solutions, is a leader in developing sophisticated prosthetic technologies for individuals with upper limb deficiencies. Their innovative product portfolio includes advanced myoelectric prosthetic hands, partial hands, and highly realistic passive silicone prostheses. The company's commitment extends beyond product development to encompass comprehensive user training and clinical support services, aiming to significantly enhance the user experience for amputees. They also provide valuable resources for individuals newly navigating limb loss and facilitate connections with certified practitioners in the field.
How much funding has Touch Bionics raised?
Touch Bionics has raised a total of $11.5M across 4 funding rounds:
Multiple Rounds
$7.7M
Unspecified
$3.9M
Unspecified (2010): $1.3M with participation from Archangels
Debt (2010): $2.5M led by Clydesdale Bank
Other Financing Round (2010): $3.9M supported by Clydesdale Bank
Unspecified (2011): $3.9M featuring Archangel Investors Limited and Scottish Venture Fund
Key Investors in Touch Bionics
Archangels
Archangels is an investment group that provides funding and support to early-stage companies, likely focusing on innovative technologies with high growth potential.
Scottish Venture Fund
The Scottish Venture Fund, managed by Scottish Enterprise, is dedicated to investing in Scottish companies with high growth potential, particularly those in technology and innovation sectors.
Clydesdale Bank
Clydesdale Bank, a prominent UK banking institution, provides a range of financial services, including debt financing and corporate banking, supporting business growth and operational needs.
What's next for Touch Bionics?
The recent major strategic investment indicates Touch Bionics is poised for significant scaling and further innovation in the prosthetics market. This capital infusion is likely to accelerate research and development efforts, potentially leading to next-generation prosthetic solutions. The company's focus on user experience and clinical support, combined with strategic backing, positions it for continued growth and market leadership. Future endeavors may include expanding their global reach and enhancing their digital support platforms for users and practitioners.
See full Touch Bionics company page
